- Published on
KembaraXtra-Medicine – Acute Lower Gastrointestinal Bleeding
Acute lower gastrointestinal (GI) bleeding is traditionally defined as bleeding that originates distal to the ligament of Treitz, though modern definitions more specifically restrict the source to the colon or rectum. It most commonly presents as hematochezia, which may appear as bright red or maroon blood per rectum, and less commonly as melena when bleeding originates from the proximal colon or small bowel. The condition is also referred to as acute colonic bleeding or gastrointestinal hemorrhage and is classified under ICD-10-CM codes K62.5, K92.1, and K92.2.
The annual incidence of hospitalization for acute lower GI bleeding in the United States ranges from approximately 33 to 87 per 100,000 individuals, representing about half the incidence of upper GI bleeding. In-hospital mortality ranges from 2.5% to 3.9%. Despite relatively low short-term mortality, recurrence is common, with rebleeding rates of 13% to 19% at one year and up to 46% at five years. The condition disproportionately affects older adults, with incidence increasing dramatically with age, particularly beyond 65 years. Elderly patients also experience higher in-hospital mortality and worse overall outcomes. Men are affected more frequently than women.
Multiple risk factors contribute to the development of acute lower GI bleeding. These include the use of antithrombotic agents, NSAIDs, aspirin, and alcohol; the presence of gastrointestinal malignancy, atrial fibrillation, coagulopathies, prior GI bleeding, cirrhosis, constipation, congenital malformations, inflammatory bowel disease, and prior radiation exposure. Additional risk factors include recent infectious illness, recent travel, abdominal aortic aneurysm repair, and portal hypertension. Among etiologies, diverticulosis is the most common cause, accounting for approximately 30% of cases, followed by internal hemorrhoids. Other causes include ischemic, infectious, or inflammatory colitis; angioectasia; rectal ulcers; postpolypectomy bleeding; neoplasms; vascular malformations; and anorectal disease. Importantly, up to 15% of patients presenting with apparent lower GI bleeding are ultimately found to have an upper GI source with rapid intestinal transit.
Clinical assessment begins with careful evaluation of hemodynamic stability and a focused history aimed at identifying the bleeding source and underlying cause. Weight loss and abdominal pain raise concern for inflammatory bowel disease or malignancy. A history of recent abdominal aortic aneurysm repair, particularly when preceded by a “sentinel bleed,” should prompt immediate concern for an aortoenteric fistula. Patients with cirrhosis may bleed from portal hypertensive sources such as colonic or rectal varices. Bright red blood per rectum typically suggests distal colonic or anorectal bleeding but may also occur in brisk upper GI hemorrhage, whereas melena generally originates from the upper GI tract, small bowel, or proximal colon. A detailed medication review is essential, particularly for NSAIDs, anticoagulants, antiplatelet agents, and beta blockers, which may blunt compensatory tachycardia.
Physical examination should include assessment of vital signs, including orthostatic measurements if the patient is stable. Clinicians should evaluate for pallor, delayed capillary refill, and signs of hypovolemia, as well as stigmata of chronic liver disease such as jaundice and telangiectasias. Abdominal examination should assess for tenderness, masses, bowel sounds, and hepatosplenomegaly, with absent bowel sounds raising concern for perforation. A rectal examination is mandatory and should document the presence, color, and volume of blood, as well as masses, fissures, hemorrhoids, tenderness, or skin changes. If no gross blood is visible, fecal occult testing should be performed. It is critical to exclude non-GI sources of bleeding, including hematuria, vaginal bleeding, and external wounds.
Initial management prioritizes airway, breathing, and circulation, with rapid establishment of large-bore intravenous access and prompt volume resuscitation. Crystalloid boluses should be administered to maintain a systolic blood pressure of at least 100 mm Hg. Blood transfusion is recommended for hemoglobin levels of 7 g/dL or less, or 8 g/dL in patients older than 65 years or those with coronary artery disease or multiple comorbidities. Platelet counts should be maintained above 50,000/µL, and the INR should be corrected to 1.5 or less when feasible. Antithrombotic agents and NSAIDs should be discontinued when possible, in consultation with the prescribing physician.
Laboratory evaluation includes serial complete blood counts to monitor hemoglobin trends, comprehensive metabolic panels to assess renal function and liver disease, coagulation studies including INR and partial thromboplastin time, and blood typing and crossmatching in anticipation of transfusion. Stool studies may be indicated when infectious colitis is suspected, and inflammatory markers may assist in identifying inflammatory or ischemic etiologies.
Imaging plays a key role in diagnosis. CT angiography is highly sensitive and specific for identifying active bleeding and abnormal vasculature and is often the preferred initial imaging modality in unstable patients. If CT angiography is nondiagnostic, a tagged red blood cell scan may be performed. CT imaging of the abdomen and pelvis may identify malignancy or other structural pathology. Plain abdominal or chest radiographs are indicated when perforation or foreign body ingestion is suspected. Ultrasound may be useful for suspected intussusception, and a technetium-99 Meckel scan is indicated when Meckel diverticulum is suspected, particularly in younger patients.
Colonoscopy remains the cornerstone of diagnosis and therapy once the patient is stabilized. It allows direct visualization of the colonic mucosa and enables therapeutic interventions such as clipping, cauterization, injection therapy, or band ligation. Anoscopy may be performed when anorectal sources such as hemorrhoids are suspected. Endoscopy is indicated when an upper GI source is suspected. Interventional radiology may be required for embolization in cases of ongoing bleeding, and surgical intervention is reserved for refractory bleeding, aortoenteric fistula, failed nonoperative management, or complications such as perforation. Balloon tamponade may be used in select cases for severe esophageal or anorectal bleeding.
Pharmacologic therapy includes proton pump inhibitors or histamine-2 receptor blockers when an upper GI source with rapid transit is suspected. Chronic management focuses on treating the underlying cause, avoiding NSAIDs and alcohol, correcting coagulopathies, and managing portal hypertension when present. Many patients are discharged on proton pump inhibitors. Fiber supplementation, stool softeners, and topical analgesic agents may reduce symptoms and recurrence of hemorrhoidal bleeding.
Most cases of acute lower GI bleeding resolve spontaneously. Hemodynamically stable patients without significant anemia or ongoing bleeding may be managed as outpatients with close follow-up by primary care or gastroenterology. Patients with hemodynamic compromise, ongoing hemorrhage, shock, or significant comorbidities require hospital admission, often to an intensive care unit, for close monitoring and urgent intervention. Clinical predictors of severe bleeding include aspirin use, the presence of two or more comorbidities, heart rate greater than 100 beats per minute, and systolic blood pressure less than 115 mm Hg. Overall mortality ranges from 2.4% to 3.9%, with age greater than 65 years, intestinal ischemia, and multiple comorbidities serving as independent predictors of in-hospital mortality. All patients should be counseled regarding the high risk of rebleeding and the importance of prompt evaluation if symptoms recur, with referral to gastroenterology for follow-up care.
0 Comments
